PSS9 Economic Burden of Wet Age-Related Macular Degeneration (WAMD) in Urban China

Y. B. Zhang,S. L. Hu,J. J. He,D. Wang

DOI: https://doi.org/10.1016/j.jval.2012.03.1353

IF: 5.156

2012-01-01

Value in Health

Abstract:This study aims to understand the direct and indirect cost of patients with wAMD in urban China, and to assess the economic burden of wAMD in real world from societal perspective. A cross-sectional study was carried out in 15 key eye centers and hospitals in 4 major cities of China (Beijing, Guangzhou, Shanghai and Chengdu) from August 2010 through April 2011. Study subjects were face-to-face interviewed by trained interviewers using structured questionnaires. Data of patients' demographics, disease history, treatment pattern and economic burden were collected based on medical charts and patient self-reports. Utilities were calculated by regression formula under various measures, including EQ-5D and NEI-VEF-25. Indirect cost was estimated by GDP per capita multiplied by DALYs and productivity weight. All cost were adjusted according to 2010 price index in China. No discount was applied. Of the 417 eligible patients, average age was 67.93 (±11.04) years old and 51.32% were male. The average wAMD onset age was 64.87(±11.72) years old with average duration of 2.93 years. A total of 130 patients were bilateral, and a total of 547 wAMD eyes were identified. On average, it costs 3,278 CNY per wAMD outpatient visit. Economic burden of wAMD per eye per year was 29,640 CNY. Based on average life expectancy at 72 years old from national statistics, economic burden of entire course of wAMD per eye was estimated to be 207,450 CNY. Given the wAMD prevalence rate at 0.34% among Chinese above 45 years old, the potential national burden of wAMD was 53.39 billion CNY per year, in which direct medical cost was 16.81 billion CNY, accounting for 31.49%. In urban China, the economic burden for wAMD is heavy both for patients and the society, while indirect cost account for majority part of the burden.